Previously, the DSRU and MEMO Research partnered to monitor the safety of the new vaccines against swine flu during the 2009 pandemic.
DSRU also carried out safety surveillance on the seasonal flu vaccine each year since 2014. This expertise in tracking seasonal influenza and swine flu vaccines’ safety is expected to support the post-marketing surveillance of Covid-19 vaccine in real-world conditions.
The consortium intends to invite individuals who have received a Covid-19 vaccine to participate in its study for follow-up.
Participants’ health will be monitored at set time-points after vaccination. It is expected that the consortium will expand and talks are underway with other interested organisations.